China Oral Industry Group Holdings Ltd. Reports 362% Increase in Net Profit to RMB 4.07 Million; EPS Rises to RMB 0.30 for H1 2025

Reuters
Aug 29, 2025
China Oral Industry Group Holdings Ltd. Reports 362% Increase in Net Profit to RMB 4.07 Million; EPS Rises to RMB 0.30 for H1 2025

China Oral Industry Group Holdings Ltd. released its unaudited interim results for the six months ended June 30, 2025. The company reported a total segment revenue of RMB 109.263 million, with the inflatable products business contributing RMB 80.872 million, the dental clinic business RMB 7.202 million, and the yarn and polyester business RMB 21.189 million. The profit for the period stood at RMB 4.069 million, an increase from RMB 880,000 in the previous period. The earnings per share were recorded at RMB 0.30, compared to RMB 0.08 in the prior period. The results indicate a significant improvement in net income and earnings per share. The company continues to operate across its three main business segments: inflatable products, dental clinic services, and yarn and polyester sales in the PRC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Oral Industry Group Holdings Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10